[By NBC-1TV H. J Yook]Vital Images, Inc., a Toshiba Medical Systems Group Company and leading provider of advanced visualization and analysis solutions for healthcare providers, received 510(k) clearance from the U.S. Food and Drug Administration for three-dimensional viewing through its universal viewer, VitreaView™. The Company also released tablet viewing capabilities for VitreaView.

Introduced in June of 2011, VitreaView provides a consistent image viewing experience across the patient continuum of care. VitreaView is used as a communication tool for DICOM and non-DICOM medical images through a standardized viewer, giving clinicians access to these images through a variety of systems, including EMR, EHR or HIE.

“Delivering high quality products is fundamentally important to Vital; seeking FDA clearance is just a part of our standard process,” said Erkan Akyuz, president and chief executive officer at Vital Images, Inc. “It is critical that our customers have confidence in the tools they depend on for delivering care. Now with 3D and tablet capabilities available via VitreaView, our customers, particularly referring physicians and clinicians, have more functionality and easier access to the tools they need. Also, with access to images through the EMR as part of the Stage 2 Meaningful Use criteria, VitreaView integrated with a certified EMR enables the ability to meet this objective, with a toolset and infrastructure that also meets the needs of clinical users and IT administrators.”